{"id":9527,"date":"2021-11-11T09:12:48","date_gmt":"2021-11-11T06:12:48","guid":{"rendered":"https:\/\/milliycha.uz\/?p=9527"},"modified":"2021-11-11T09:12:49","modified_gmt":"2021-11-11T06:12:49","slug":"antikoagulyantlar","status":"publish","type":"post","link":"https:\/\/milliycha.uz\/kr\/antikoagulyantlar\/","title":{"rendered":"ANTIKOAGULYANTLAR"},"content":{"rendered":"\n<p>ANTIKOAGULYANTLAR (anti&#8230; va lotincha coagulatio \u2014 ivitmoq) \u2014 qon ivishini susaytiruvchi dorilar, ular qon ivishining kuchayishi bilan bog&#8217;liq bo&#8217;lgan kasallik holatlarining (trombozlar, tromboemboliyalar, tromboflebitlar) oldini olish va davolash maqsadida ishlatiladi. Antikoagulyantlarning 2 xili farq qilinadi. Bevosita ta&#8217;sir etuvchi Antikoagulyantlar (geparin va geparinoidlar) organizmda ham, organizmdan tashqarida ham qon ivishiga to&#8217;sqinlik qiladi, venaga yuborilganda darrov ta&#8217;sir ko&#8217;rsatadi. Bilvosita ta&#8217;sir etuvchi Antikoagulyantlar (dikumarin, neodikumarin, shuningdek, fenilin, omefin va boshqalar) faqat organizmda qon ivishiga to&#8217;sqinlik qiladi. Bular ichiladi, eritmalari to&#8217;g&#8217;ri ichakka va venaga yuboriladi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ANTIKOAGULYANTLAR (anti&#8230; va lotincha coagulatio \u2014 ivitmoq) \u2014 qon ivishini susaytiruvchi dorilar, ular qon ivishining kuchayishi bilan bog&#8217;liq bo&#8217;lgan kasallik holatlarining (trombozlar, tromboemboliyalar, tromboflebitlar) oldini olish va davolash maqsadida ishlatiladi. &hellip; <a href=\"https:\/\/milliycha.uz\/kr\/antikoagulyantlar\/\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":9243,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[107],"tags":[],"class_list":["post-9527","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-a-harfi","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"kr","enabled_languages":["uz","kr","ru"],"languages":{"uz":{"title":true,"content":true,"excerpt":false},"kr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/posts\/9527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/comments?post=9527"}],"version-history":[{"count":1,"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/posts\/9527\/revisions"}],"predecessor-version":[{"id":9530,"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/posts\/9527\/revisions\/9530"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/media\/9243"}],"wp:attachment":[{"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/media?parent=9527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/categories?post=9527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/milliycha.uz\/kr\/wp-json\/wp\/v2\/tags?post=9527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}